- Statement of Changes in Beneficial Ownership (4)
July 17 2009 - 5:18PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Expires:
February 28, 2011
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Ogren D John
|
2. Issuer Name
and
Ticker or Trading Symbol
CORE LABORATORIES N V
[
CLB
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__
X
__ Director
_____ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Last)
(First)
(Middle)
12568 MEMORIAL DRIVE
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
7/15/2009
|
(Street)
HOUSTON, TX 77024
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Restricted Performance Shares
|
$0.00
|
7/15/2009
|
|
A
|
|
1157
|
|
(1)
|
(1)
|
Common Shares
|
1157
|
$0.00
|
1157
|
D
|
|
Explanation of Responses:
|
(
1)
|
The Restricted Performance Shares vest based on the Company's return on equity for the period that begins on July 15, 2009 and ends on July 15, 2012 (the "performance period") as follows: (a) if the Company's return on equity for the performance period equals or exceeds the 75th percentile of the return on equity of the members of the S&P 500 Oil & Gas Equipment and Services Index, then the Restricted Performance Shares will fully vest; (b) if the Company's return on equity for the performance period is less than the 75th percentile of the measure described above but equal to or more than the 50th percentile, then fifty-percent (50%) of the Restricted Performance Shares will vest, plus a straight line pro rata amount between the 50th percentile and the 75th percentile; and (c) if the Company's return on equity for the performance period is less than the 50th percentile of the measure described above, the Restricted Performance Shares will not vest.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Ogren D John
12568 MEMORIAL DRIVE
HOUSTON, TX 77024
|
X
|
|
|
|
Signatures
|
Mark F. Elvig, as Attorney-in-Fact
|
|
7/17/2009
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Core Laboratories (NYSE:CLB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Core Laboratories (NYSE:CLB)
Historical Stock Chart
From Sep 2023 to Sep 2024